Literature DB >> 24672213

Ingenol mebutate gel (picato): a novel agent for the treatment of actinic keratoses.

Brooke Fidler, Tamara Goldberg.   

Abstract

Ingenol mebutate gel (Picato) for actinic keratoses.

Entities:  

Year:  2014        PMID： 24672213      PMCID： PMC3956386     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  11 in total

Review 1.  Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response.

Authors:  Robert H Rosen; Aditya K Gupta; Stephen K Tyring
Journal:  J Am Acad Dermatol       Date:  2011-11-04       Impact factor: 11.527

2.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

Authors:  Howard W Rogers; Martin A Weinstock; Ashlynne R Harris; Michael R Hinckley; Steven R Feldman; Alan B Fleischer; Brett M Coldiron
Journal:  Arch Dermatol       Date:  2010-03

Review 3.  Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine.

Authors:  G Appendino; A Szallasi
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

4.  Facial resurfacing for nonmelanoma skin cancer prophylaxis.

Authors:  Basil M Hantash; Daniel B Stewart; Zachary A Cooper; Wingfield E Rehmus; R James Koch; Susan M Swetter
Journal:  Arch Dermatol       Date:  2006-08

5.  Ingenol mebutate gel for actinic keratosis.

Authors:  Mark Lebwohl; Neil Swanson; Lawrence L Anderson; Anita Melgaard; Zhenyi Xu; Brian Berman
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

6.  The risk of progression to invasive disease.

Authors:  R G Glogau
Journal:  J Am Acad Dermatol       Date:  2000-01       Impact factor: 11.527

7.  Ingenol mebutate: an introduction.

Authors:  Robyn S Fallen; Melinda Gooderham
Journal:  Skin Therapy Lett       Date:  2012-02

8.  UV doses of young adults.

Authors:  Dianne E Godar; Frederick Urbach; Francis P Gasparro; Jan C van der Leun
Journal:  Photochem Photobiol       Date:  2003-04       Impact factor: 3.421

9.  Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.

Authors:  R Kaufmann; L Spelman; W Weightman; J Reifenberger; R-M Szeimies; E Verhaeghe; N Kerrouche; V Sorba; H Villemagne; L E Rhodes
Journal:  Br J Dermatol       Date:  2008-03-13       Impact factor: 9.302

10.  Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.

Authors:  Lawrence Anderson; George J Schmieder; W Philip Werschler; Eduardo H Tschen; Mark R Ling; Dow B Stough; Janelle Katsamas
Journal:  J Am Acad Dermatol       Date:  2009-06       Impact factor: 11.527
View more
  7 in total

1.  Ingenol mebutate treatment in keloids.

Authors:  Bruna De Felice; Marco Guida; Luigi Boccia; Massimo Nacca
Journal:  BMC Res Notes       Date:  2015-09-22

2.  Ingenol mebutate: a succinct review of a succinct therapy.

Authors:  David Rhys Alchin
Journal:  Dermatol Ther (Heidelb)       Date:  2014-08-27

3.  Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency.

Authors:  Pargol Hashemi; Kris Barreto; Wendy Bernhard; Adam Lomness; Nicolette Honson; Tom A Pfeifer; P Richard Harrigan; Ivan Sadowski
Journal:  EMBO Mol Med       Date:  2018-02       Impact factor: 12.137

Review 4.  Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Authors:  Nevena Skroza; Nicoletta Bernardini; Ilaria Proietti; Concetta Potenza
Journal:  Ther Clin Risk Manag       Date:  2018-10-04       Impact factor: 2.423

5.  Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation.

Authors:  Guochun Jiang; Erica A Mendes; Philipp Kaiser; Daniel P Wong; Yuyang Tang; Ivy Cai; Anne Fenton; Gregory P Melcher; James E K Hildreth; George R Thompson; Joseph K Wong; Satya Dandekar
Journal:  PLoS Pathog       Date:  2015-07-30       Impact factor: 6.823

6.  In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation.

Authors:  Jessica Brogdon; Widade Ziani; Xiaolei Wang; Ronald S Veazey; Huanbin Xu
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

7.  Dynamic Control of ERG20 and ERG9 Expression for Improved Casbene Production in Saccharomyces cerevisiae.

Authors:  Roberta Callari; Yvan Meier; Davide Ravasio; Harald Heider
Journal:  Front Bioeng Biotechnol       Date:  2018-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.